Ningbo MedicalSystem Biotechnology Co Ltd (300439.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE100001Z25

Price
9.54 CNY
Market cap
3.67 bn CNY
P/E (2025)
58.01
P/S (2025)
2.38
Dividend yield
0.35 %
Net margin
4.11 %
Return on equity (ROE)
2.14 %
Return on assets (ROA)
1.73 %

Ningbo MedicalSystem Biotechnology Co Ltd financials

Fiscal year20242025
Revenue1.74 bn CNY1.54 bn CNY
Gross profit769.70 m CNY566.42 m CNY
Operating income267.53 m CNY61.40 m CNY
EBIT285.08 m CNY48.66 m CNY
Net income258.00 m CNY63.20 m CNY
Diluted EPS – continuing operations0.67 CNY0.16 CNY

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Ningbo MedicalSystem Biotechnology Co Ltd

Medicalsystem Biotechnology Co., Ltd. researches, develops, produces, and sells in vitro diagnostic products in China. It is also involved in the provision of third-party medical diagnostic services. The company offers chemiluminescence, biochemistry, integrated combination, TLA system, hematology, point-of-care testing (POCT), mass spectrometry, and blood lipid subfraction analysis. It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Biotechnology Co., Ltd. in January 2017. The company was founded in 2003 and is based in Ningbo, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.